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Abstract
We performed a Web-based survey on attitudes and uptake of
H1N1 inﬂuenza vaccination among members of two European
societies, namely the European Respiratory Society and the Euro-
pean Society of Clinical Microbiology and Infectious Diseases. A
multidisciplinary panel developed a questionnaire that examined
physicians’ and members’ knowledge, attitudes and practice about
seasonal and pandemic (H1N1) inﬂuenza vaccination. In all, 1334
healthcare workers from 83 countries (785 men and 549 women,
mean age 45 ± 7 years) accessed and completed the survey. Safety
concerns about vaccines was the main reason reported by 451/
1285 respondents for not being vaccinated. More than 30% of
1282 respondents considered the management of communication
on the ﬂu pandemic by health authorities to be insufﬁcient. The
results of this survey should help health authorities to better design
future steps for the successful vaccination of healthcare workers.
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Population protection through vaccination against infections
has been one of the major achievements of public health. The
recent H1N1 inﬂuenza virus pandemic reopened the discus-
sion on the strategic arrangements for vaccination in the face
of spreading infection. Even though vaccination against a pan-
demic strain is considered to be one of the most effective
countermeasures for protecting individuals, the general accep-
tance of H1N1 inﬂuenza vaccination has been low worldwide.
To date, we know very little about how people, and in
particular healthcare workers, react in a pandemic such as
inﬂuenza A (H1N1): only a limited number of studies have
addressed the behavioural responses to an inﬂuenza pan-
demic [1,2]. The most common barriers were fear of
adverse effects, uncertainty about the vaccine’s efﬁcacy, and
misconceptions about the vaccine and the nature of the
infection [3–8]. It is worth noting that one medical centre in
the USA made ﬂu vaccination a mandatory condition of con-
tinued employment, which emphasizes the intrinsic resistance
that healthcare workers have to this issue [9].
As major H1N1 vaccine campaigns got underway, scien-
tiﬁc societies and many authoritative sources raised concerns
about the lack of uptake as the result of both public scepti-
cism and deliberate misinformation being raised by a growing
anti-vaccination lobby who actively contested both the need
and safety of the pandemic inﬂuenza vaccine across Europe.
They feared that a low uptake of the vaccine could greatly
hamper efforts to control the pandemic and increase pres-
sure on health systems across Europe, and called for a con-
certed and coordinated effort by national and European
authorities to counter anti-vaccine propaganda.
For these reasons, we decided to perform a Web-survey
on vaccination and attitudes to vaccination among the mem-
bership of two European societies, namely the European
Respiratory Society (ERS) and the European Society of Clini-
cal Microbiology and Infectious Diseases (ESCMID), dealing
with respiratory infections.
The Web-based survey was conducted between 21
December 2009 and 22 January 2010 at a time to coincide
with peak pandemic activity and when the impact on health-
care systems and publicity was at its greatest. A question-
naire was prepared by a multidisciplinary specialist panel
including respiratory diseases (F.B., G.R.), microbiology and
infectious diseases (R.F.) and internal medicine (P.P.) with the
support of the ERS and ESCMID ofﬁces. The questionnaire
was promoted through the newsletters of the societies, their
websites and mailing lists and it was constructed to examine
respondents’ knowledge, attitudes and practice in relation
to seasonal and pandemic (H1N1) inﬂuenza vaccination. A
structured format was adopted, using multiple-choice
responses modiﬁed to create a user-friendly Web-based
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questionnaire. Questions were presented as a series of
linked pages (multiple-item screens) with progress indicators.
Questions were ordered on the basis of content: (i) broad
questions on respondents, demographics and professional
data; (ii) speciﬁc questions, addressing respondents’ experi-
ence and conﬁdence with vaccination; and (iii) questions
regarding the respondents’ personal experience with inﬂu-
enza vaccination. Twenty-one questions were included in the
questionnaire (Table 1).
Respondents had the possibility to include additional free
comments.
Responses were obtained from 1334 persons from 83
countries (785 men and 549 women, mean age 45 ± 7 years)
who accessed and completed the survey. Of those complet-
ing the questionnaire, 1001 were healthcare workers from
Europe, 176 were from Asia-Paciﬁc, 92 were from America,
and 65 were from Africa–Middle East. More than 90% of
respondents were members of ERS (70%) or ESCMID (22%).
This means that about 9% of the approximately 13 500
members of the two societies took part in the survey. Sea-
sonal and H1N1 vaccinations were reported by 741/1277
(58%) and 834/1285 (64.9%) of respondents, respectively and
both vaccinations were reported by 576/1226 (47%). Among
the 834 respondents who received the H1N1 vaccination,
the main reasons for vaccination were to ‘avoid virus spread
to patients’ and to ‘protect myself’.
The main reasons reported by 451/1285 respondents for
not having the H1N1 vaccination are shown in Fig. 1. Over-
all, safety was the main concern. Another important issue
raised by both vaccinated and non-vaccinated respondents
was the nature of the health authorities’ management of
communications during the inﬂuenza pandemic. More than
30% of 1282 respondents rated the communication to be
suboptimal. Most of the 1211 respondents recommended
H1N1 vaccination to patients, mainly those designated high-
risk. With regard to families, 39.2% would recommend the
vaccine to all family members, 33.0% to high-risk family
members and 27.7% would not recommend it at all.
The survey highlights the inadequate manner in which risk
was dealt with by public health authorities because it fea-
tured prominently in the open comments from respondents
in many countries. This, together with the massive media
campaigns, impaired the smooth running of the vaccination
programme campaign. Healthcare workers also identiﬁed
concerns about the safety of pandemic inﬂuenza vaccine not
only in relation to possible adverse effects but also with
regard to a lack of conﬁdence in vaccine manufacturers.
These concerns may be in part explained by the fact that at
the time of the survey the safety data were somewhat uncer-
tain and were largely those contained in the dossier for
licensing. Our study has limitations. First, we cannot rule out
a selection bias in our online sample, which was conducted
by two professional societies whose membership has a
TABLE 1. Web-based survey questionnaire
Question Answers
Country of residence
Year of birth
Gender Male
Female
Household includes Children under 5
Children aged 5–18
Adults over 18
High-risk relatives
I am a member of ERS
ESCMID
Both
None
If I am an ERS member, I
belong to
Assembly number
I mostly work as A respiratory physician in clinical
practice
A respiratory physician in private
practice
A respiratory specialist in research
An academic infectious disease specialist
An infectious disease specialist (hospital)
An academic clinical microbiologist
A clinical microbiologist (hospital)
An academic in medical schools
A research scientist
A general practitioner
An allied health professional
Other (specify)
My average time spent in
contact with patients
0–25%
25–50%
50–75%
75–100%
Have you been considered
to have the H1N1 infection
Yes
No
If YES, have you been
tested positive for H1N1
Yes
No
Did you get the seasonal
ﬂu vaccine
Yes
No
Did you get the H1N1
vaccine
Yes
No
Did you get both vaccines
this season
Yes
No
If you chose to have the
H1N1 vaccine, what was
the main reason (more
than one option possible)
Protect myself
Avoid virus spread to patients
Protect my household contacts
If you chose not to have
the H1N1 vaccine, what
was the main reason (more
than one option possible)
The vaccine was developed too quickly
I am concerned about adverse effects
The vaccine is dangerous
The H1N1 virus is not dangerous
I disapprove of the way in which health
authorities communicated with us
concerning this issue in my country
I had no time
I think I already had the H1N1 ﬂu
Was the H1N1
vaccination mandatory in
your institution
Yes
No
Did you recommend the
vaccine to your
co-workers
Yes
No
Did you recommend the
vaccine to your household/
family
Yes to all household/family members
Yes only to high-risk household/family
members
No
Did you recommend the
vaccine to your patients
Yes to all patients
Yes to high-risk patients only
No
How would you rate the
communication from your
health authorities with
regard to the ﬂu pandemic
Totally insufﬁcient
Insufﬁcient
Adequate
Good
Excellent
Do you have any
comments on this issue
Open
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particular interest in respiratory and infectious diseases. This
possible selection bias is mirrored in the Italian example
where the ofﬁcial statistics indicate vaccine uptake among
healthcare workers of around 15% [Flunews: http://www.
epicentro.iss.it (accessed on 18 June 2010)] whereas in our
survey the vaccination rate appeared to be as high as 50%.
Second, an online survey shares with other survey methods
the general limitation that the results are based on respon-
dents’ self-declarations. On the other hand the advantage of
a Web-based sampling strategy is the ability to quickly deploy
a survey and thereby track responses in close to real-time of
the risk perceptions and attitudes toward pandemic vaccina-
tion of a potentially large sample of healthcare workers
worldwide. In fact, the survey provided a good assessment
of the willingness of many healthcare workers to accept pan-
demic inﬂuenza vaccination, so long as the concerns over
vaccination production and safety can be better addressed
[10]. With regard to future strategies to improve vaccination
acceptance by healthcare workers, different approaches will
need to be considered, such as implementation of educa-
tional tools or even mandatory vaccination, as recently sug-
gested [11]. We believe that the results of this survey can
help health authorities to better design any future vaccina-
tion programmes for healthcare workers, taking into account
their opinions on the contentious issues identiﬁed in this sur-
vey. This is desirable because it is well known that vaccinat-
ing healthcare workers against inﬂuenza is not only a simple
and cost-effective measure to reduce infection among staff
but also an excellent tool to prevent morbidity and mortality
among patients [12,13]. As the results of this survey show,
healthcare workers are aware of these data and are support-
ive of protecting their own health and limiting the trans-
mission of infection to their patients and this should be
exploited in future vaccination campaigns.
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FIG. 1. Main reasons for not having H1N1 vaccination (more than
one answer allowed) reported by 471 respondents.
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